Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Guy P. Sansone, a director at CVS Health Corp (NYSE:CVS), recently acquired 1,570 shares of the company’s common stock. The transaction, completed on June 5, 2025, was valued at approximately $100,009, with each share priced at $63.70. The purchase comes as CVS trades at attractive valuations, with a P/E ratio of 15.16 and an appealing dividend yield of 4.18%. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value estimates. Following this acquisition, Sansone’s total direct ownership stands at 12,007.355 shares. This move highlights continued confidence in CVS Health’s prospects by its board members, particularly noteworthy given the company’s strong 44.91% year-to-date return and its position as a prominent player in the Healthcare Providers & Services industry. Want deeper insights into insider trading patterns and 8 additional InvestingPro Tips for CVS? Access the comprehensive Pro Research Report covering 1,400+ top stocks.
In other recent news, CVS Health has made headlines with several key developments. The company has proposed acquiring a significant number of Rite Aid (NYSE:US90274J5618=UBSS) stores and patient data in the Pacific Northwest, as Rite Aid winds down operations after filing for bankruptcy. This acquisition would bolster CVS’s presence in a region where it currently has fewer stores per capita. Meanwhile, CVS Health’s first-quarter earnings surpassed expectations, prompting JPMorgan to raise its price target for the company to $86 while maintaining an Overweight rating. Analyst Lisa Gill highlighted CVS’s strong performance in its Patient Care Work and Health Services Segment as factors contributing to the positive outlook.
Additionally, Cantor Fitzgerald reaffirmed its Overweight rating on CVS Health, citing understated enrollment figures that could indicate conservative consensus estimates. The analysts noted that CVS Health’s enrollment might not fully reflect recent contract gains, suggesting potential growth. In related industry news, the Centers for Medicare & Medicaid Services announced an expansion of audits for Medicare Advantage plans, which could impact funding and regulatory environments. KeyBanc maintains a Sector Weight stance on Humana (NYSE:HUM) and Alignment Healthcare, with an Overweight position on UnitedHealth Group (NYSE:UNH), noting that sector challenges could be resolved by 2026. These recent developments underscore the dynamic environment in which CVS Health and its industry peers operate.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.